J. Vičar
Impact in
-
- Protease and Inhibitor Mechanisms
-
- Berberine and alkaloids research
Papers in
-
- Protease and Inhibitor Mechanisms 6
-
- Berberine and alkaloids research 6
- Co-authors
- K. Bláha (11 shared papers)Evzen Krepela (7 shared papers)Miloš Buděšı́nský (2 shared papers)Jitka Ulrichová A (5 shared papers)Vilı́m Šimánek (4 shared papers)Pierre Fromageot (4 shared papers)Serge Fermandjian (4 shared papers)Ivo Frič (3 shared papers)
In The Last Decade
J. Vičar
26 papers receiving 400 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 75
- Pharmacology 52
- Spectroscopy 51
- Molecular Biology 169
- Animal Science and Zoology 22
Countries citing papers authored by J. Vičar
This map shows the geographic impact of J. Vičar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Vičar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Vičar more than expected).
Fields of papers citing papers by J. Vičar
This network shows the impact of papers produced by J. Vičar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Vičar. The network helps show where J. Vičar may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Vičar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 51 | |
| 2 | 1973 | 41 | |
| 3 | 1987 | 36 | |
| 4 | 2007 | 34 | |
| 5 | 1975 | 32 | |
| 6 | Cathepsin B in human breast tumor tissue and cancer cells. | 1989 | 26 |
| 7 | 1976 | 24 | |
| 8 | 1979 | 24 | |
| 9 | 2003 | 24 | |
| 10 | 1973 | 22 | |
| 11 | 1972 | 17 | |
| 12 | 1972 | 16 | |
| 13 | Quaternary benzo[c]phenanthridine alkaloids as inhibitors of dipeptidyl peptidase IV-like activity baring enzymes in human blood plasma and glioma cell lines. | 2003 | 15 |
| 14 | Demonstration of two molecular forms of dipeptidyl peptidase IV in normal human serum. | 1983 | 13 |
| 15 | 1973 | 12 | |
| 16 | 2003 | 12 | |
| 17 | An assay of dipeptidyl peptidase IV activity in human serum and serum of pregnant women with glycyl-L-proline-1-naphthylamide and other glycyl-L-proline-arylamides as substrates. | 1983 | 10 |
| 18 | 1977 | 9 | |
| 19 | 1977 | 8 | |
| 20 | 1979 | 7 |
About J. Vičar
J. Vičar is a scholar working on Cancer Research, Pharmacology, Molecular Biology, Oncology and Spectroscopy, having authored 27 papers that have together received 458 indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (8 papers), Protease and Inhibitor Mechanisms (6 papers), Berberine and alkaloids research (6 papers), Peptidase Inhibition and Analysis (4 papers), Structural and Chemical Analysis of Organic and Inorganic Compounds (3 papers), Advanced NMR Techniques and Applications (3 papers), Protein Structure and Dynamics (3 papers) and Plant Toxicity and Pharmacological Properties (2 papers). The work is most often cited by research in Cancer Research (75 citations), Pharmacology (52 citations), Spectroscopy (51 citations), Molecular Biology (169 citations) and Animal Science and Zoology (22 citations). J. Vičar has collaborated with scholars based in Czechia and France. Frequent co-authors include K. Bláha, Evzen Krepela, Miloš Buděšı́nský, Jitka Ulrichová A, Vilı́m Šimánek, Pierre Fromageot, Serge Fermandjian, Ivo Frič, Aleksi Šedo and David Rasnick. Their work appears in journals such as Physiological Research, FEBS Letters, Biopolymers, Journal of Cell Science and Xenobiotica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.